Krebs Biochemicals Industr Q1 Results Live loss falls by 3.03 percent YOY Company Business News - Mint
| KREBSBIO | 109.74 5.60 5.38% |
Under 54% of Krebs Biochemicals' traders are presently thinking to get in. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that some investors are interested at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
Krebs |
Krebs Biochemicals Industr Q1 Results Live loss falls by 3.03 percent YOY Company Business News Mint
Read at news.google.com
 |
Krebs Biochemicals Fundamental Analysis
We analyze Krebs Biochemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Krebs Biochemicals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Krebs Biochemicals and Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Krebs Biochemicals stock to make a market-neutral strategy. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with similar companies.
Peers
Krebs Biochemicals Related Equities
| RELIANCE | Reliance Industries | 1.31 | ||||
| BHARTIARTL | Bharti Airtel | 1.01 | ||||
| HDFCBANK | HDFC Bank | 0.48 | ||||
| TCS | Tata Consultancy | 0.14 |
Complementary Tools for Krebs Stock analysis
When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |